Literature DB >> 2037853

A randomized clinical trial of negative pressure ventilation in severe chronic obstructive pulmonary disease: design and methods.

S H Shapiro1, P T Macklem, K Gray-Donald, J G Martin, P P Ernst, S Wood-Dauphinee, T A Hutchinson, W O Spitzer.   

Abstract

This report documents the design and methods of a randomized clinical trial designed to test the effectiveness of home negative pressure ventilation in patients with severe chronic obstructive pulmonary disease. Active negative pressure ventilation was compared with a sham version of the treatment after a pre-trial assessment had indicated the feasibility of the latter. Over 1200 patients in the metropolitan Montreal area were screened. Of these, 348 patients were recruited to enter a 4-week stabilization period, and 184 were subsequently randomized to receive either active or sham negative pressure ventilation. A 5-day in-hospital period was used to train patients in ventilator use and obtain baseline measures of exercise capacity, lung function, respiratory symptoms, and quality of life. Home ventilation treatment took place during a following 12-week period. Respirator use was recorded both from patient logs and from concealed meters installed in the units. Patients received four home visits by physiotherapists during the 12-week period and returned for follow-up to the hospital 4 and 12 weeks post-discharge for reassessment.

Entities:  

Mesh:

Year:  1991        PMID: 2037853     DOI: 10.1016/0895-4356(91)90211-q

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  2 in total

1.  Induction of sleep apnoea with negative pressure ventilation in patients with chronic obstructive lung disease.

Authors:  R D Levy; M G Cosio; L Gibbons; P T Macklem; J G Martin
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

2.  Domiciliary ventilation in chronic obstructive lung disease.

Authors:  P M Calverley
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.